A significant breakthrough in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently inactivated in several kinds of tumors, leading https://travialist.com/story12401440/nanobodies-revive-p53-a-new-hope-for-malignant-treatment